Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-3-12
pubmed:abstractText
CD38 is a progression marker in HIV-1 infection, it displays lateral association with CD4, and down-modulates gp120/CD4 binding. The aim of this study was to elucidate the mechanism behind the interplay between CD4, CD38, and HIV-1. We used mouse cell transfectants expressing human CD4 and either CD38 or other CD4-associated molecules to show that CD38 specifically inhibits gp120/CD4 binding. Human cell transfectants expressing truncated forms of CD38 and bioinformatic analysis were used to map the anti-HIV activity and show that it is concentrated in the membrane-proximal region. This region displayed significant sequence-similarity with the V3 loop of the HIV-1 gp120 glycoprotein. In line with this similarity, synthetic soluble peptides derived from this region reproduced the anti-HIV effects of full-length CD38 and inhibited HIV-1 and HIV-2 primary isolates from different subtypes and with different coreceptor use. A multiple-branched peptide construct presenting part of the sequence of the V3-like region potently and selectively inhibited HIV-1 replication in the nanomolar range. Conversely, a deletion in the V3-like region abrogated the anti-HIV-1 activity of CD38 and its lateral association with CD4. These findings may provide new insights into the early events of HIV-1 fusion and strategies to intervene.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1530-6860
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
461-3
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:12551845-ADP-ribosyl Cyclase, pubmed-meshheading:12551845-Amino Acid Motifs, pubmed-meshheading:12551845-Animals, pubmed-meshheading:12551845-Antigens, CD, pubmed-meshheading:12551845-Antigens, CD38, pubmed-meshheading:12551845-Antigens, CD4, pubmed-meshheading:12551845-Cell Line, pubmed-meshheading:12551845-Down-Regulation, pubmed-meshheading:12551845-HIV Envelope Protein gp120, pubmed-meshheading:12551845-HIV Fusion Inhibitors, pubmed-meshheading:12551845-HIV-1, pubmed-meshheading:12551845-Humans, pubmed-meshheading:12551845-Membrane Fusion, pubmed-meshheading:12551845-Membrane Glycoproteins, pubmed-meshheading:12551845-Mice, pubmed-meshheading:12551845-Models, Biological, pubmed-meshheading:12551845-Peptides, pubmed-meshheading:12551845-Protein Structure, Tertiary, pubmed-meshheading:12551845-Receptors, Virus, pubmed-meshheading:12551845-Sequence Homology, Amino Acid, pubmed-meshheading:12551845-Transfection, pubmed-meshheading:12551845-Virus Replication
pubmed:year
2003
pubmed:articleTitle
Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.
pubmed:affiliation
Laboratory of Immunology, Interdisciplinary Research Center of Autoimmune Diseases, Department of Medical Science, University of Eastern Piedmont, Novara, Italy. asavarino@medscape.com
pubmed:publicationType
Journal Article